"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","20/32","481/2914",5.06225611772473e-09,2.47723449829666e-06,1.46192346661015e-06,"FOXO1/AKT1/SIRT1/SMAD3/EP300/CDK1/MAPK1/ESR1/RB1/PPP2CA/CSNK2A1/SMAD1/CREB1/YAP1/SMAD2/BRCA1/TP53/CTNNB1/PPP2R1B/STAT1",20
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","20/32","499/2914",9.84983895943008e-09,2.47723449829666e-06,1.46192346661015e-06,"FOXO1/AKT1/SIRT1/SMAD3/EP300/CDK1/MAPK1/ESR1/RB1/PPP2CA/CSNK2A1/SMAD1/CREB1/YAP1/SMAD2/BRCA1/TP53/CTNNB1/PPP2R1B/STAT1",20
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","15/32","268/2914",2.62838540525557e-08,4.40692619614518e-06,2.60071819046341e-06,"STAT3/FOXO1/AKT1/SMAD3/EP300/MAPK1/ESR1/PPP2CA/CREB1/GSK3A/AMER1/SMAD2/CTNNB1/PPP2R1B/STAT1",15
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","8/32","62/2914",1.86635458110267e-07,2.34694088573661e-05,1.38503155755514e-05,"AKT1/CDK1/MAPK1/ESR1/RB1/SMAD1/YAP1/STAT1",8
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","11/32","172/2914",9.61715751253744e-07,8.07735480735759e-05,4.76679722857558e-05,"FOXO1/AKT1/MAPK1/ESR1/EGR1/PPP2CA/CSNK2A1/CREB1/GSK3A/TP53/PPP2R1B",11
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","6/32","33/2914",9.63501567478043e-07,8.07735480735759e-05,4.76679722857558e-05,"PLK1/CDK1/MAPK1/RB1/PPP2CA/PPP2R1B",6
"R-HSA-1643685","R-HSA-1643685","Disease","16/32","443/2914",3.57680876587279e-06,0.000219732374035374,0.000129673599409805,"STAT3/FOXO1/AKT1/SMAD3/EP300/MAPK1/ESR1/PPP2CA/CREB1/GSK3A/AMER1/SMAD2/NFKB1/CTNNB1/PPP2R1B/STAT1",16
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","4/32","11/2914",3.74966358557602e-06,0.000219732374035374,0.000129673599409805,"CDK1/RB1/PPP2CA/PPP2R1B",4
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","5/32","24/2914",4.23205605245849e-06,0.000219732374035374,0.000129673599409805,"MAPK1/PPP2CA/RPS6KA3/CREB1/PPP2R1B",5
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","11/32","201/2914",4.5744900185633e-06,0.000219732374035374,0.000129673599409805,"FOXO1/AKT1/MAPK1/ESR1/EGR1/PPP2CA/CSNK2A1/CREB1/GSK3A/TP53/PPP2R1B",11
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","15/32","397/2914",4.95817515333302e-06,0.000219732374035374,0.000129673599409805,"STAT3/FOXO1/AKT1/SMAD3/EP300/MAPK1/CSNK2A1/ROCK2/RPS6KA3/CREB1/CEBPA/PAK1/SMAD2/NFKB1/CTNNB1",15
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","8/32","95/2914",5.24212423146021e-06,0.000219732374035374,0.000129673599409805,"AKT1/EP300/CDK1/PPP2CA/CSNK2A1/BRCA1/TP53/PPP2R1B",8
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","6/32","49/2914",1.07498396668698e-05,0.000272419282612357,0.000160766428160897,"FOXO1/AKT1/SIRT1/SMAD3/EP300/SMAD2",6
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","4/32","14/2914",1.11134227641955e-05,0.000272419282612357,0.000160766428160897,"PPP2CA/AMER1/CTNNB1/PPP2R1B",4
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","4/32","14/2914",1.11134227641955e-05,0.000272419282612357,0.000160766428160897,"PPP2CA/AMER1/CTNNB1/PPP2R1B",4
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","4/32","14/2914",1.11134227641955e-05,0.000272419282612357,0.000160766428160897,"PPP2CA/AMER1/CTNNB1/PPP2R1B",4
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","4/32","14/2914",1.11134227641955e-05,0.000272419282612357,0.000160766428160897,"PPP2CA/AMER1/CTNNB1/PPP2R1B",4
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","4/32","14/2914",1.11134227641955e-05,0.000272419282612357,0.000160766428160897,"PPP2CA/AMER1/CTNNB1/PPP2R1B",4
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","4/32","14/2914",1.11134227641955e-05,0.000272419282612357,0.000160766428160897,"PPP2CA/AMER1/CTNNB1/PPP2R1B",4
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","5/32","29/2914",1.13733696518081e-05,0.000272419282612357,0.000160766428160897,"AKT1/CDK1/PPP2CA/TP53/PPP2R1B",5
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","5/32","29/2914",1.13733696518081e-05,0.000272419282612357,0.000160766428160897,"AKT1/CDK1/PPP2CA/TP53/PPP2R1B",5
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","5/32","30/2914",1.35423152596788e-05,0.00030962657161902,0.000182724062355475,"MAPK1/PPP2CA/RPS6KA3/CREB1/PPP2R1B",5
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","4/32","16/2914",1.98964759517746e-05,0.000435127278423593,0.000256787469949677,"PPP2CA/AMER1/CTNNB1/PPP2R1B",4
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","10/32","191/2914",2.09772682919317e-05,0.000439648581285069,0.000259455686768629,"AKT1/EP300/PLK1/CDK1/MAPK1/RB1/PPP2CA/CSNK2A1/TP53/PPP2R1B",10
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","13/32","347/2914",3.23364511551084e-05,0.000637253870772534,0.000376071134368221,"STAT3/AKT1/MAPK1/ESR1/PPP2CA/ROCK2/RPS6KA3/CREB1/YAP1/PAK1/CTNNB1/PPP2R1B/STAT1",13
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","4/32","18/2914",3.2939563896791e-05,0.000637253870772534,0.000376071134368221,"PLK1/CDK1/PPP2CA/PPP2R1B",4
"R-HSA-450294","R-HSA-450294","MAP kinase activation","6/32","60/2914",3.53439419537084e-05,0.000652347436675624,0.000384978501920113,"MAPK1/PPP2CA/RPS6KA3/CREB1/NFKB1/PPP2R1B",6
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","11/32","249/2914",3.63135750038121e-05,0.000652347436675624,0.000384978501920113,"AKT1/EP300/PLK1/CDK1/MAPK1/RB1/PPP2CA/CSNK2A1/BRCA1/TP53/PPP2R1B",11
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","8/32","124/2914",3.81679590886784e-05,0.000662016669710525,0.000390684735499358,"SMAD3/EP300/CDK1/ESR1/SMAD1/SMAD2/BRCA1/TP53",8
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","6/32","64/2914",5.13147018618985e-05,0.000860376501217832,0.000507745471054575,"MAPK1/PPP2CA/RPS6KA3/CREB1/NFKB1/PPP2R1B",6
"R-HSA-69275","R-HSA-69275","G2/M Transition","6/32","66/2914",6.1229764178613e-05,0.000989503376878192,0.000583948838086534,"EP300/PLK1/CDK1/PPP2CA/TP53/PPP2R1B",6
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","4/32","21/2914",6.29505130419526e-05,0.000989503376878192,0.000583948838086534,"MAPK1/PPP2CA/RPS6KA3/PPP2R1B",4
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","6/32","68/2914",7.26256314699021e-05,0.0011069906857382,0.000653283192169454,"EP300/PLK1/CDK1/PPP2CA/TP53/PPP2R1B",6
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","6/32","70/2914",8.56603964945582e-05,0.0012672699834342,0.000747870953915338,"STAT3/MAPK1/PPP2CA/RPS6KA3/CREB1/PPP2R1B",6
"R-HSA-68886","R-HSA-68886","M Phase","7/32","105/2914",0.000103308015644057,0.00144553819184325,0.000853074751699899,"PLK1/CDK1/MAPK1/RB1/PPP2CA/CSNK2A1/PPP2R1B",7
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","12/32","332/2914",0.000106549747458584,0.00144553819184325,0.000853074751699899,"STAT3/FOXO1/AKT1/SMAD3/MAPK1/PPP2CA/RPS6KA3/CREB1/NFKB1/TP53/PPP2R1B/STAT1",12
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","4/32","24/2914",0.000109205668568675,0.00144553819184325,0.000853074751699899,"FOXO1/AKT1/CREB1/GSK3A",4
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","4/32","24/2914",0.000109205668568675,0.00144553819184325,0.000853074751699899,"MAPK1/RB1/SMAD1/YAP1",4
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","9/32","187/2914",0.000117490290922902,0.00151532349574922,0.000894258084757312,"STAT3/SIRT1/EP300/MAPK1/RB1/RPS6KA3/NFKB1/TP53/ARNT",9
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","7/32","108/2914",0.000123673864661128,0.00155519884811368,0.000917790258801,"AKT1/EP300/PPP2CA/CSNK2A1/AMER1/CTNNB1/PPP2R1B",7
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","9/32","189/2914",0.000127649850740108,0.00156604572981157,0.000924191473907843,"STAT3/SIRT1/EP300/MAPK1/RB1/RPS6KA3/NFKB1/TP53/ARNT",9
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","3/32","10/2914",0.000137091008586287,0.00160364598416052,0.00094638101398612,"RB1/PPP2CA/PPP2R1B",3
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","3/32","10/2914",0.000137091008586287,0.00160364598416052,0.00094638101398612,"FOXO1/SIRT1/EP300",3
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","6/32","78/2914",0.000157704903092497,0.00172446883164187,0.0010176838140065,"MAPK1/PPP2CA/RPS6KA3/CREB1/NFKB1/PPP2R1B",6
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","6/32","78/2914",0.000157704903092497,0.00172446883164187,0.0010176838140065,"MAPK1/PPP2CA/RPS6KA3/CREB1/NFKB1/PPP2R1B",6
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","6/32","78/2914",0.000157704903092497,0.00172446883164187,0.0010176838140065,"MAPK1/PPP2CA/RPS6KA3/CREB1/NFKB1/PPP2R1B",6
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","4/32","27/2914",0.000176235897204291,0.00188609907007997,0.00111306882444815,"STAT3/EP300/CREB1/CEBPA",4
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","6/32","83/2914",0.000222923360448847,0.00233605104803687,0.00137860499224945,"MAPK1/PPP2CA/RPS6KA3/CREB1/NFKB1/PPP2R1B",6
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","5/32","53/2914",0.000228013726316374,0.00234063070075788,0.00138130764385,"SMAD3/EP300/YAP1/TP53/CTNNB1",5
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","6/32","84/2914",0.00023821353041476,0.00234943932938479,0.00138650599746052,"MAPK1/PPP2CA/RPS6KA3/CREB1/NFKB1/PPP2R1B",6
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","6/32","84/2914",0.00023821353041476,0.00234943932938479,0.00138650599746052,"MAPK1/PPP2CA/RPS6KA3/CREB1/NFKB1/PPP2R1B",6
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","3/32","12/2914",0.000247598279824174,0.00239503720676076,0.00141341528158739,"MAPK1/PPP2CA/PPP2R1B",3
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","4/32","30/2914",0.000268899908735772,0.00239846803233034,0.00141543996048374,"PPP2CA/AMER1/CTNNB1/PPP2R1B",4
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","6/32","86/2914",0.000271280087844717,0.00239846803233034,0.00141543996048374,"MAPK1/PPP2CA/RPS6KA3/CREB1/NFKB1/PPP2R1B",6
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","6/32","86/2914",0.000271280087844717,0.00239846803233034,0.00141543996048374,"MAPK1/PPP2CA/RPS6KA3/CREB1/NFKB1/PPP2R1B",6
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","6/32","86/2914",0.000271280087844717,0.00239846803233034,0.00141543996048374,"MAPK1/PPP2CA/RPS6KA3/CREB1/NFKB1/PPP2R1B",6
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","6/32","87/2914",0.000289119368120682,0.00239846803233034,0.00141543996048374,"MAPK1/PPP2CA/RPS6KA3/CREB1/NFKB1/PPP2R1B",6
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","6/32","87/2914",0.000289119368120682,0.00239846803233034,0.00141543996048374,"MAPK1/PPP2CA/RPS6KA3/CREB1/NFKB1/PPP2R1B",6
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","6/32","87/2914",0.000289119368120682,0.00239846803233034,0.00141543996048374,"MAPK1/PPP2CA/RPS6KA3/CREB1/NFKB1/PPP2R1B",6
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","5/32","56/2914",0.000296499259033287,0.00239846803233034,0.00141543996048374,"PLK1/CDK1/PPP2CA/CSNK2A1/PPP2R1B",5
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","4/32","31/2914",0.000306363374445317,0.00239846803233034,0.00141543996048374,"PPP2CA/AMER1/CTNNB1/PPP2R1B",4
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","3/32","13/2914",0.000319477849236845,0.00239846803233034,0.00141543996048374,"PPP2CA/AMER1/PPP2R1B",3
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","3/32","13/2914",0.000319477849236845,0.00239846803233034,0.00141543996048374,"PPP2CA/AMER1/PPP2R1B",3
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","3/32","13/2914",0.000319477849236845,0.00239846803233034,0.00141543996048374,"PPP2CA/AMER1/PPP2R1B",3
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","3/32","13/2914",0.000319477849236845,0.00239846803233034,0.00141543996048374,"PPP2CA/AMER1/PPP2R1B",3
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","3/32","13/2914",0.000319477849236845,0.00239846803233034,0.00141543996048374,"PPP2CA/AMER1/PPP2R1B",3
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","3/32","13/2914",0.000319477849236845,0.00239846803233034,0.00141543996048374,"PPP2CA/AMER1/PPP2R1B",3
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","6/32","89/2914",0.000327572076334713,0.00242306991759354,0.00142995859947971,"STAT3/MAPK1/PPP2CA/RPS6KA3/CREB1/PPP2R1B",6
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","6/32","90/2914",0.000348252319921801,0.00250244167029523,0.00147679931154809,"MAPK1/PPP2CA/RPS6KA3/CREB1/NFKB1/PPP2R1B",6
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","6/32","90/2914",0.000348252319921801,0.00250244167029523,0.00147679931154809,"MAPK1/PPP2CA/RPS6KA3/CREB1/NFKB1/PPP2R1B",6
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","5/32","59/2914",0.00037962829835239,0.00268947935311623,0.00158717835634357,"AKT1/MAPK1/EGR1/CSNK2A1/TP53",5
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","7/32","130/2914",0.000395529206072833,0.00274323447097628,0.00161890158169993,"PLK1/MAPK1/PPP2CA/ROCK2/PAK1/CTNNB1/PPP2R1B",7
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","3/32","14/2914",0.00040357723827484,0.00274323447097628,0.00161890158169993,"AKT1/EP300/TP53",3
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","3/32","14/2914",0.00040357723827484,0.00274323447097628,0.00161890158169993,"FOXO1/SMAD3/SMAD2",3
"R-HSA-69206","R-HSA-69206","G1/S Transition","5/32","60/2914",0.000410926876206816,0.00275594958309371,0.00162640532056592,"AKT1/CDK1/RB1/PPP2CA/PPP2R1B",5
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","4/32","34/2914",0.000441213104187492,0.00292013409745143,0.00172329771995669,"PLK1/CDK1/PPP2CA/PPP2R1B",4
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","3/32","15/2914",0.000500712032613726,0.00327088509616499,0.00193029108950199,"EP300/CDK1/TP53",3
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","6/32","99/2914",0.00058438193309376,0.00376851426084822,0.00222396363201674,"STAT3/MAPK1/RB1/RPS6KA3/NFKB1/TP53",6
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","3/32","16/2914",0.000611669468766481,0.00386029923078176,0.00227812992169186,"PLK1/CDK1/TP53",3
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","4/32","37/2914",0.000613964092370856,0.00386029923078176,0.00227812992169186,"PPP2CA/AMER1/CTNNB1/PPP2R1B",4
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","6/32","104/2914",0.000761143194504698,0.00472660526957856,0.00278937466991975,"AKT1/SMAD3/EP300/CREB1/TP53/STAT1",6
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","8/32","194/2914",0.000875520582972992,0.005321272729589,0.00314031371715831,"AKT1/EP300/CDK1/PPP2CA/CSNK2A1/BRCA1/TP53/PPP2R1B",8
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","3/32","18/2914",0.00087806289573735,0.005321272729589,0.00314031371715831,"MAPK1/RPS6KA3/CREB1",3
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","6/32","110/2914",0.00102533798615664,0.00591560423795885,0.00349105450477011,"MAPK1/PPP2CA/RPS6KA3/CREB1/NFKB1/PPP2R1B",6
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","3/32","19/2914",0.00103493672552759,0.00591560423795885,0.00349105450477011,"AKT1/PPP2CA/PPP2R1B",3
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","3/32","19/2914",0.00103493672552759,0.00591560423795885,0.00349105450477011,"EP300/PAK1/NFKB1",3
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","3/32","19/2914",0.00103493672552759,0.00591560423795885,0.00349105450477011,"MAPK1/RB1/YAP1",3
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","3/32","19/2914",0.00103493672552759,0.00591560423795885,0.00349105450477011,"FOXO1/SMAD3/SMAD2",3
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","3/32","20/2914",0.00120850997610969,0.0068301181795862,0.00403074882629132,"MAPK1/CSNK2A1/PAK1",3
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","6/32","114/2914",0.00123752099582455,0.00691636734333051,0.00408164819675464,"PLK1/CDK1/PPP2CA/BRCA1/TP53/PPP2R1B",6
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","5/32","77/2914",0.00130216777654397,0.00711966021030851,0.00420162013039029,"AKT1/CDK1/RB1/PPP2CA/PPP2R1B",5
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","4/32","45/2914",0.0013022042531777,0.00711966021030851,0.00420162013039029,"STAT3/MAPK1/RPS6KA3/NFKB1",4
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","3/32","22/2914",0.0016083453177789,0.0086988999445461,0.00513359795827561,"MAPK1/RPS6KA3/CREB1",3
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","4/32","49/2914",0.0017955486687364,0.00960809553589798,0.00567015369074653,"STAT3/AKT1/MAPK1/TP53",4
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","3/32","23/2914",0.00183584060547334,0.00972029289003253,0.00573636621322418,"MAPK1/RB1/TP53",3
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","3/32","24/2914",0.00208250273931686,0.0106887640599631,0.00630790303423581,"FOXO1/AKT1/EP300",3
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","3/32","24/2914",0.00208250273931686,0.0106887640599631,0.00630790303423581,"AKT1/MAPK1/CREB1",3
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","3/32","24/2914",0.00208250273931686,0.0106887640599631,0.00630790303423581,"STAT3/MAPK1/STAT1",3
"R-HSA-195721","R-HSA-195721","Signaling by WNT","7/32","172/2914",0.00211238492999822,0.0107326224221122,0.0063337857550186,"AKT1/EP300/PPP2CA/CSNK2A1/AMER1/CTNNB1/PPP2R1B",7
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","6/32","127/2914",0.00216746192140404,0.0109023334646623,0.00643393959827305,"MAPK1/PPP2CA/RPS6KA3/CREB1/NFKB1/PPP2R1B",6
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","3/32","25/2914",0.00234888853293485,0.0116979300204577,0.00690345561529576,"AKT1/PAK1/CTNNB1",3
"R-HSA-373760","R-HSA-373760","L1CAM interactions","4/32","53/2914",0.00240622210749189,0.0117507739812468,0.00693464112736548,"MAPK1/CSNK2A1/RPS6KA3/PAK1",4
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","4/32","53/2914",0.00240622210749189,0.0117507739812468,0.00693464112736548,"AKT1/PPP2CA/PAK1/PPP2R1B",4
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","5/32","92/2914",0.00288343457535392,0.0139458422250291,0.00823004605515997,"AKT1/MAPK1/ESR1/PPP2CA/PPP2R1B",5
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","3/32","27/2914",0.00294294377222249,0.014098102070742,0.00831990119064403,"CDK1/ESR1/TP53",3
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","5/32","94/2914",0.00316866316450145,0.0150362035070211,0.00887351551528709,"STAT3/FOXO1/AKT1/TP53/STAT1",5
"R-HSA-111885","R-HSA-111885","Opioid Signalling","4/32","59/2914",0.00357096543315186,0.0166183353319043,0.00980720009123578,"MAPK1/PPP2CA/CREB1/PPP2R1B",4
"R-HSA-141424","R-HSA-141424","Amplification of signal from the kinetochores","3/32","29/2914",0.0036220092741046,0.0166183353319043,0.00980720009123578,"PLK1/PPP2CA/PPP2R1B",3
"R-HSA-141444","R-HSA-141444","Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","3/32","29/2914",0.0036220092741046,0.0166183353319043,0.00980720009123578,"PLK1/PPP2CA/PPP2R1B",3
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","5/32","97/2914",0.00363422840260333,0.0166183353319043,0.00980720009123578,"FOXO1/AKT1/ESR1/CREB1/GSK3A",5
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","5/32","99/2914",0.00397090895274985,0.0177811701029027,0.0104934392989821,"AKT1/MAPK1/ESR1/PPP2CA/PPP2R1B",5
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","3/32","30/2914",0.00399457698136781,0.0177811701029027,0.0104934392989821,"STAT3/CSNK2A1/TP53",3
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","3/32","30/2914",0.00399457698136781,0.0177811701029027,0.0104934392989821,"EP300/CDK1/TP53",3
"R-HSA-109581","R-HSA-109581","Apoptosis","5/32","101/2914",0.00432955736206651,0.0191032223957847,0.0112736396685388,"STAT3/AKT1/MAPK1/TP53/CTNNB1",5
"R-HSA-391251","R-HSA-391251","Protein folding","3/32","31/2914",0.00438974272496665,0.0192003529622455,0.0113309606264585,"STAT3/CSNK2A1/TP53",3
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","4/32","63/2914",0.00453189142105654,0.0196512188344089,0.0115970361228489,"AKT1/MAPK1/ESR1/CREB1",4
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","5/32","103/2914",0.00471096552911667,0.0202531253089375,0.0119522472263689,"STAT3/AKT1/MAPK1/TP53/CTNNB1",5
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","3/32","32/2914",0.00480791218445167,0.020494744311688,0.0120948370741781,"MAPK1/EGR1/TP53",3
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","2/32","10/2914",0.0049773818321121,0.0206910996822511,0.0122107148904359,"AKT1/TP53",2
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","2/32","10/2914",0.0049773818321121,0.0206910996822511,0.0122107148904359,"STAT3/STAT1",2
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","2/32","10/2914",0.0049773818321121,0.0206910996822511,0.0122107148904359,"STAT3/STAT1",2
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","3/32","34/2914",0.00571478658190781,0.0230232635522196,0.0135870258903964,"EP300/NFKB1/CTNNB1",3
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","3/32","34/2914",0.00571478658190781,0.0230232635522196,0.0135870258903964,"MAPK1/PPP2CA/PPP2R1B",3
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","3/32","34/2914",0.00571478658190781,0.0230232635522196,0.0135870258903964,"FOXO1/CDK1/PAK1",3
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","5/32","108/2914",0.00576923716326387,0.0230232635522196,0.0135870258903964,"AKT1/EP300/MAPK1/ESR1/CREB1",5
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","2/32","11/2914",0.00604189023636778,0.0230232635522196,0.0135870258903964,"STAT3/STAT1",2
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","2/32","11/2914",0.00604189023636778,0.0230232635522196,0.0135870258903964,"FOXO1/AKT1",2
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","2/32","11/2914",0.00604189023636778,0.0230232635522196,0.0135870258903964,"EP300/CREB1",2
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","2/32","11/2914",0.00604189023636778,0.0230232635522196,0.0135870258903964,"STAT3/SMAD2",2
"R-HSA-5627117","R-HSA-5627117","RHO GTPases Activate ROCKs","2/32","11/2914",0.00604189023636778,0.0230232635522196,0.0135870258903964,"ROCK2/PAK1",2
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","2/32","11/2914",0.00604189023636778,0.0230232635522196,0.0135870258903964,"STAT3/STAT1",2
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","2/32","11/2914",0.00604189023636778,0.0230232635522196,0.0135870258903964,"FOXO1/AKT1",2
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","2/32","12/2914",0.0072007486276765,0.0270296758188155,0.0159513834485842,"SMAD3/SMAD2",2
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","2/32","12/2914",0.0072007486276765,0.0270296758188155,0.0159513834485842,"STAT3/STAT1",2
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","2/32","13/2914",0.00845188876921098,0.0308065221080661,0.0181802641717582,"AKT1/GSK3A",2
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","2/32","13/2914",0.00845188876921098,0.0308065221080661,0.0181802641717582,"EP300/BRCA1",2
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","2/32","13/2914",0.00845188876921098,0.0308065221080661,0.0181802641717582,"EP300/TP53",2
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","2/32","13/2914",0.00845188876921098,0.0308065221080661,0.0181802641717582,"FOXO1/EP300",2
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","3/32","40/2914",0.00902375828593886,0.0319644395621637,0.0188636014576335,"EP300/CEBPA/NFKB1",3
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","3/32","40/2914",0.00902375828593886,0.0319644395621637,0.0188636014576335,"RB1/PPP2CA/PPP2R1B",3
"R-HSA-69236","R-HSA-69236","G1 Phase","3/32","40/2914",0.00902375828593886,0.0319644395621637,0.0188636014576335,"RB1/PPP2CA/PPP2R1B",3
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","3/32","40/2914",0.00902375828593886,0.0319644395621637,0.0188636014576335,"AKT1/SMAD3/EP300",3
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","2/32","14/2914",0.009793274024367,0.0344476701696266,0.0203290634881965,"MAPK1/PPP2CA",2
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","7/32","228/2914",0.0101262135036688,0.0353714263357321,0.0208742120470366,"PLK1/MAPK1/PPP2CA/ROCK2/PAK1/CTNNB1/PPP2R1B",7
"R-HSA-69618","R-HSA-69618","Mitotic Spindle Checkpoint","3/32","42/2914",0.0103304758778287,0.0358360645968815,0.0211484152272064,"PLK1/PPP2CA/PPP2R1B",3
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","4/32","80/2914",0.0105578405713879,0.0363739301877269,0.0214658330290656,"SMAD3/SMAD1/SMAD2/TP53",4
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","2/32","15/2914",0.0112228989461752,0.0376341211328409,0.0222095263355888,"SMAD3/SMAD2",2
"R-HSA-176412","R-HSA-176412","Phosphorylation of the APC/C","2/32","15/2914",0.0112228989461752,0.0376341211328409,0.0222095263355888,"PLK1/CDK1",2
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","2/32","15/2914",0.0112228989461752,0.0376341211328409,0.0222095263355888,"PPP2CA/PPP2R1B",2
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","2/32","15/2914",0.0112228989461752,0.0376341211328409,0.0222095263355888,"STAT3/SMAD3",2
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","4/32","85/2914",0.0130070280741113,0.0433280471607814,0.0255697589187828,"AKT1/ROCK2/PAK1/CTNNB1",4
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","3/32","46/2914",0.0132604163664087,0.04388150942305,0.0258963809925711,"CDK1/BRCA1/TP53",3
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","4/32","86/2914",0.013537137759764,0.0445044463605314,0.0262640030839591,"EP300/ESR1/CSNK2A1/YAP1",4
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","3/32","47/2914",0.0140598736406795,0.0456265576855599,0.0269262096208599,"MAPK1/RPS6KA3/CREB1",3
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","3/32","47/2914",0.0140598736406795,0.0456265576855599,0.0269262096208599,"PLK1/PPP2CA/PPP2R1B",3
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","2/32","17/2914",0.0143389995201089,0.0462340817859922,0.0272847359289522,"SMAD3/EP300",2
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","5/32","136/2914",0.0149744764614967,0.0479755519753683,0.0283124529811737,"AKT1/EP300/MAPK1/ESR1/CREB1",5
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","3/32","49/2914",0.0157401685929135,0.0497943698253805,0.0293858162409905,"SIRT1/EP300/MAPK1",3
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","3/32","49/2914",0.0157401685929135,0.0497943698253805,0.0293858162409905,"MAPK1/RPS6KA3/CREB1",3
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","2/32","18/2914",0.0160216165981554,0.0500551127259139,0.0295396919299105,"EP300/CSNK2A1",2
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","2/32","18/2914",0.0160216165981554,0.0500551127259139,0.0295396919299105,"EP300/STAT1",2
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","4/32","92/2914",0.0170101068936372,0.0528153318981452,0.031168616920115,"AKT1/ROCK2/PAK1/CTNNB1",4
"R-HSA-2980766","R-HSA-2980766","Nuclear Envelope Breakdown","2/32","19/2914",0.0177847554066998,0.0548817912243558,0.0323881241503994,"PLK1/CDK1",2
"R-HSA-400253","R-HSA-400253","Circadian Clock","3/32","52/2914",0.018465725930186,0.0566357325785584,0.0334232009776153,"SIRT1/EP300/CREB1",3
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","2/32","20/2914",0.0196265604545431,0.058762856599019,0.0346785090738168,"SMAD3/SMAD2",2
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","2/32","20/2914",0.0196265604545431,0.058762856599019,0.0346785090738168,"MAPK1/RPS6KA3",2
"R-HSA-70171","R-HSA-70171","Glycolysis","2/32","20/2914",0.0196265604545431,0.058762856599019,0.0346785090738168,"PPP2CA/PPP2R1B",2
"R-HSA-70326","R-HSA-70326","Glucose metabolism","2/32","20/2914",0.0196265604545431,0.058762856599019,0.0346785090738168,"PPP2CA/PPP2R1B",2
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","6/32","202/2914",0.0204087626462929,0.0607432403022801,0.0358472193475839,"FOXO1/CDK1/MAPK1/PPP2CA/PAK1/PPP2R1B",6
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","2/32","21/2914",0.0215452050757279,0.0637484597240656,0.037620729605915,"AKT1/PAK1",2
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","9/32","393/2914",0.0216870455275233,0.0637928883061064,0.0376469488381752,"SMAD3/EP300/CDK1/ESR1/SMAD1/SMAD2/BRCA1/TP53/FBXO22",9
"R-HSA-2467813","R-HSA-2467813","Separation of Sister Chromatids","3/32","56/2914",0.0224860137554407,0.0653784099363391,0.0385826338852101,"PLK1/PPP2CA/PPP2R1B",3
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","3/32","56/2914",0.0224860137554407,0.0653784099363391,0.0385826338852101,"CSNK2A1/BRCA1/TP53",3
"R-HSA-180024","R-HSA-180024","DARPP-32 events","2/32","22/2914",0.0235388910515228,0.067273080675659,0.0397007612232622,"PPP2CA/PPP2R1B",2
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","2/32","22/2914",0.0235388910515228,0.067273080675659,0.0397007612232622,"EP300/CTNNB1",2
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","2/32","22/2914",0.0235388910515228,0.067273080675659,0.0397007612232622,"SMAD3/SMAD2",2
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","2/32","23/2914",0.0256058482368609,0.071953864039894,0.0424630944004397,"CDK1/MAPK1",2
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","2/32","23/2914",0.0256058482368609,0.071953864039894,0.0424630944004397,"EP300/TP53",2
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","2/32","23/2914",0.0256058482368609,0.071953864039894,0.0424630944004397,"STAT3/STAT1",2
"R-HSA-68882","R-HSA-68882","Mitotic Anaphase","3/32","60/2914",0.0269500891670656,0.0753105269501889,0.0444440066965644,"PLK1/PPP2CA/PPP2R1B",3
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","2/32","24/2914",0.0277443341911831,0.0754345951252166,0.0445172247050562,"EP300/ARNT",2
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","2/32","24/2914",0.0277443341911831,0.0754345951252166,0.0445172247050562,"STAT3/STAT1",2
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","2/32","24/2914",0.0277443341911831,0.0754345951252166,0.0445172247050562,"SMAD3/SMAD2",2
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","2/32","24/2914",0.0277443341911831,0.0754345951252166,0.0445172247050562,"RB1/TP53",2
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","2/32","24/2914",0.0277443341911831,0.0754345951252166,0.0445172247050562,"STAT3/STAT1",2
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","4/32","107/2914",0.0280031008669387,0.075680008838556,0.0446620539760862,"EP300/ESR1/BRCA1/TP53",4
"R-HSA-2555396","R-HSA-2555396","Mitotic Metaphase and Anaphase","3/32","61/2914",0.028135510244155,0.075680008838556,0.0446620539760862,"PLK1/PPP2CA/PPP2R1B",3
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","3/32","62/2914",0.0293486571333869,0.0780630819080863,0.0460684087016435,"CDK1/BRCA1/TP53",3
"R-HSA-2990846","R-HSA-2990846","SUMOylation","4/32","109/2914",0.0297290538858287,0.0780630819080863,0.0460684087016435,"EP300/ESR1/BRCA1/TP53",4
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","2/32","25/2914",0.0299526338136395,0.0780630819080863,0.0460684087016435,"PLK1/CDK1",2
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","2/32","25/2914",0.0299526338136395,0.0780630819080863,0.0460684087016435,"PLK1/CDK1",2
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","2/32","25/2914",0.0299526338136395,0.0780630819080863,0.0460684087016435,"EP300/ESR1",2
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","2/32","25/2914",0.0299526338136395,0.0780630819080863,0.0460684087016435,"AKT1/CSNK2A1",2
"R-HSA-111996","R-HSA-111996","Ca-dependent events","2/32","26/2914",0.0322290589826003,0.0822904399403449,0.0485631559342414,"MAPK1/CREB1",2
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","2/32","26/2914",0.0322290589826003,0.0822904399403449,0.0485631559342414,"PLK1/CDK1",2
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","2/32","26/2914",0.0322290589826003,0.0822904399403449,0.0485631559342414,"PLK1/CDK1",2
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","2/32","26/2914",0.0322290589826003,0.0822904399403449,0.0485631559342414,"ESR1/STAT1",2
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","2/32","27/2914",0.0345719481994305,0.0865158703697191,0.0510567656048149,"ESR1/YAP1",2
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","2/32","27/2914",0.0345719481994305,0.0865158703697191,0.0510567656048149,"PLK1/CDK1",2
"R-HSA-380287","R-HSA-380287","Centrosome maturation","2/32","27/2914",0.0345719481994305,0.0865158703697191,0.0510567656048149,"PLK1/CDK1",2
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","2/32","27/2914",0.0345719481994305,0.0865158703697191,0.0510567656048149,"MAPK1/PPP2CA",2
"R-HSA-168249","R-HSA-168249","Innate Immune System","9/32","428/2914",0.0358452854874113,0.0892583099018212,0.0526751980586242,"EP300/MAPK1/PPP2CA/RPS6KA3/CREB1/PAK1/NFKB1/CTNNB1/PPP2R1B",9
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","2/32","28/2914",0.0369796662364808,0.0907354737412187,0.0535469364759311,"SMAD3/SMAD2",2
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","2/32","28/2914",0.0369796662364808,0.0907354737412187,0.0535469364759311,"PLK1/CDK1",2
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","2/32","28/2914",0.0369796662364808,0.0907354737412187,0.0535469364759311,"MAPK1/PPP2CA",2
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","2/32","29/2914",0.0394506037892494,0.0944935890761545,0.055764763250969,"AKT1/TP53",2
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","2/32","29/2914",0.0394506037892494,0.0944935890761545,0.055764763250969,"STAT3/STAT1",2
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","2/32","29/2914",0.0394506037892494,0.0944935890761545,0.055764763250969,"EP300/TP53",2
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","2/32","29/2914",0.0394506037892494,0.0944935890761545,0.055764763250969,"EP300/CREB1",2
"R-HSA-5673000","R-HSA-5673000","RAF activation","2/32","29/2914",0.0394506037892494,0.0944935890761545,0.055764763250969,"PPP2CA/PPP2R1B",2
"R-HSA-176814","R-HSA-176814","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","2/32","30/2914",0.0419831771326695,0.099143371350858,0.0585088013413037,"PLK1/CDK1",2
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","2/32","30/2914",0.0419831771326695,0.099143371350858,0.0585088013413037,"MAPK1/PAK1",2
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","2/32","30/2914",0.0419831771326695,0.099143371350858,0.0585088013413037,"MAPK1/PPP2CA",2
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","3/32","72/2914",0.0429931028155896,0.101053881851596,0.0596362764092291,"EP300/PAK1/NFKB1",3
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","2/32","31/2914",0.0445758277814766,0.103325536286095,0.0609768781682095,"AKT1/CTNNB1",2
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","2/32","31/2914",0.0445758277814766,0.103325536286095,0.0609768781682095,"AKT1/PAK1",2
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","2/32","31/2914",0.0445758277814766,0.103325536286095,0.0609768781682095,"STAT3/STAT1",2
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","2/32","32/2914",0.0472270221546115,0.107489557211627,0.0634342474284375,"SIRT1/MAPK1",2
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","2/32","32/2914",0.0472270221546115,0.107489557211627,0.0634342474284375,"MAPK1/CREB1",2
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","2/32","32/2914",0.0472270221546115,0.107489557211627,0.0634342474284375,"STAT3/STAT1",2
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","2/32","32/2914",0.0472270221546115,0.107489557211627,0.0634342474284375,"MAPK1/PPP2CA",2
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","3/32","77/2914",0.0508291042553944,0.115166844326412,0.0679649473685216,"MAPK1/RPS6KA3/CREB1",3
"R-HSA-112040","R-HSA-112040","G-protein mediated events","2/32","34/2914",0.0526990302849723,0.116261457163777,0.0686109258557811,"MAPK1/CREB1",2
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","2/32","34/2914",0.0526990302849723,0.116261457163777,0.0686109258557811,"MAPK1/CREB1",2
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","2/32","34/2914",0.0526990302849723,0.116261457163777,0.0686109258557811,"PLK1/CDK1",2
"R-HSA-3928662","R-HSA-3928662","EPHB-mediated forward signaling","2/32","34/2914",0.0526990302849723,0.116261457163777,0.0686109258557811,"ROCK2/PAK1",2
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","2/32","34/2914",0.0526990302849723,0.116261457163777,0.0686109258557811,"BRCA1/TP53",2
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","2/32","34/2914",0.0526990302849723,0.116261457163777,0.0686109258557811,"BRCA1/TP53",2
"R-HSA-422475","R-HSA-422475","Axon guidance","6/32","254/2914",0.0544564090117916,0.119613859095769,0.0705893235638944,"MAPK1/CSNK2A1/ROCK2/RPS6KA3/CREB1/PAK1",6
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","2/32","35/2914",0.0555168984363555,0.12088744551293,0.0713409221191718,"AKT1/TP53",2
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","2/32","35/2914",0.0555168984363555,0.12088744551293,0.0713409221191718,"BRCA1/TP53",2
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","3/32","80/2914",0.0558462249189375,0.121080392819938,0.0714547886893846,"PLK1/CDK1/CREB1",3
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","2/32","36/2914",0.0583874184567383,0.126046658728495,0.074385597491756,"SMAD3/SMAD2",2
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","3/32","82/2914",0.0593198498737764,0.127512326865425,0.0752505517966934,"STAT3/SMAD3/NFKB1",3
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","2/32","37/2914",0.0613091763903211,0.129573595480385,0.0764669957632488,"SIRT1/EP300",2
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","2/32","37/2914",0.0613091763903211,0.129573595480385,0.0764669957632488,"PLK1/CDK1",2
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","2/32","37/2914",0.0613091763903211,0.129573595480385,0.0764669957632488,"MAPK1/PPP2CA",2
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","2/32","37/2914",0.0613091763903211,0.129573595480385,0.0764669957632488,"EP300/STAT1",2
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","2/32","38/2914",0.0642807812542388,0.134721804045342,0.0795051768144533,"ROCK2/PAK1",2
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","2/32","38/2914",0.0642807812542388,0.134721804045342,0.0795051768144533,"MAPK1/PPP2CA",2
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","3/32","86/2914",0.0665701299929048,0.138940976707183,0.0819950935051284,"SMAD3/SMAD1/SMAD2",3
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","2/32","39/2914",0.0673008647300026,0.139885681649551,0.0825526048449792,"AKT1/RB1",2
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","3/32","87/2914",0.0684447428599051,0.141677801063919,0.0836102122005339,"MAPK1/PAK1/NFKB1",3
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","3/32","88/2914",0.0703437815904757,0.143300180857873,0.0845676488477979,"MAPK1/RPS6KA3/CREB1",3
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","2/32","40/2914",0.0703680808586375,0.143300180857873,0.0845676488477979,"PLK1/CDK1",2
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","2/32","40/2914",0.0703680808586375,0.143300180857873,0.0845676488477979,"PLK1/CDK1",2
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","2/32","40/2914",0.0703680808586375,0.143300180857873,0.0845676488477979,"AKT1/RB1",2
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","2/32","41/2914",0.0734811057394746,0.147843984747823,0.0872491444990814,"STAT3/STAT1",2
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","2/32","41/2914",0.0734811057394746,0.147843984747823,0.0872491444990814,"STAT3/STAT1",2
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","2/32","41/2914",0.0734811057394746,0.147843984747823,0.0872491444990814,"MAPK1/PPP2CA",2
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","2/32","42/2914",0.076638637232557,0.152368515920854,0.089919266484631,"PPP2CA/PPP2R1B",2
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","2/32","42/2914",0.076638637232557,0.152368515920854,0.089919266484631,"PLK1/CDK1",2
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","2/32","42/2914",0.076638637232557,0.152368515920854,0.089919266484631,"EGR1/STAT1",2
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","2/32","43/2914",0.0798393946646199,0.158107147701984,0.0933058818707949,"MAPK1/PAK1",2
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","2/32","44/2914",0.0830821185386069,0.162608193093071,0.0959621438783008,"ESR1/YAP1",2
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","2/32","44/2914",0.0830821185386069,0.162608193093071,0.0959621438783008,"MAPK1/TP53",2
"R-HSA-71387","R-HSA-71387","Metabolism of carbohydrates","2/32","44/2914",0.0830821185386069,0.162608193093071,0.0959621438783008,"PPP2CA/PPP2R1B",2
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","2/32","45/2914",0.086365570246681,0.168379386953801,0.0993679755592168,"STAT3/STAT1",2
"R-HSA-1430728","R-HSA-1430728","Metabolism","6/32","289/2914",0.0903829227229542,0.175531313241876,0.103588637300846,"AKT1/EP300/PPP2CA/CSNK2A1/ARNT/PPP2R1B",6
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","2/32","47/2914",0.0930498054820717,0.178641420448405,0.105424046387884,"EP300/ARNT",2
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","2/32","47/2914",0.0930498054820717,0.178641420448405,0.105424046387884,"STAT3/AKT1",2
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","2/32","47/2914",0.0930498054820717,0.178641420448405,0.105424046387884,"STAT3/AKT1",2
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","8/32","436/2914",0.0935685338564862,0.178954268174192,0.105608671392952,"AKT1/MAPK1/PPP2CA/ROCK2/RPS6KA3/CREB1/PAK1/PPP2R1B",8
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","2/32","48/2914",0.0964482137050898,0.183763073839622,0.108446556079886,"EP300/ARNT",2
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","6/32","296/2914",0.0988759914205578,0.187412755723252,0.110600391574672,"AKT1/PPP2CA/PAK1/NFKB1/FBXO22/PPP2R1B",6
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","2/32","49/2914",0.0998825986034802,0.187412755723252,0.110600391574672,"STAT3/STAT1",2
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","2/32","49/2914",0.0998825986034802,0.187412755723252,0.110600391574672,"EP300/ESR1",2
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","2/32","50/2914",0.103351821830356,0.187412755723252,0.110600391574672,"MAPK1/PPP2CA",2
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","1/32","10/2914",0.104697782024321,0.187412755723252,0.110600391574672,"CDK1",1
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","1/32","10/2914",0.104697782024321,0.187412755723252,0.110600391574672,"MAPK1",1
"R-HSA-1221632","R-HSA-1221632","Meiotic synapsis","1/32","10/2914",0.104697782024321,0.187412755723252,0.110600391574672,"BRCA1",1
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","1/32","10/2914",0.104697782024321,0.187412755723252,0.110600391574672,"CDK1",1
"R-HSA-209560","R-HSA-209560","NF-kB is activated and signals survival","1/32","10/2914",0.104697782024321,0.187412755723252,0.110600391574672,"NFKB1",1
"R-HSA-211945","R-HSA-211945","Phase I - Functionalization of compounds","1/32","10/2914",0.104697782024321,0.187412755723252,0.110600391574672,"ARNT",1
"R-HSA-381038","R-HSA-381038","XBP1(S) activates chaperone genes","1/32","10/2914",0.104697782024321,0.187412755723252,0.110600391574672,"GSK3A",1
"R-HSA-442729","R-HSA-442729","CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde","1/32","10/2914",0.104697782024321,0.187412755723252,0.110600391574672,"CREB1",1
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","1/32","10/2914",0.104697782024321,0.187412755723252,0.110600391574672,"MAPK1",1
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","1/32","10/2914",0.104697782024321,0.187412755723252,0.110600391574672,"EP300",1
"R-HSA-74749","R-HSA-74749","Signal attenuation","1/32","10/2914",0.104697782024321,0.187412755723252,0.110600391574672,"MAPK1",1
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","1/32","10/2914",0.104697782024321,0.187412755723252,0.110600391574672,"CSNK2A1",1
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","1/32","10/2914",0.104697782024321,0.187412755723252,0.110600391574672,"MAPK1",1
"R-HSA-112316","R-HSA-112316","Neuronal System","3/32","105/2914",0.106154166750767,0.189345907360411,0.111741228158702,"MAPK1/RPS6KA3/CREB1",3
"R-HSA-1358803","R-HSA-1358803","Downregulation of ERBB2:ERBB3 signaling","1/32","11/2914",0.114563371203117,0.197347177106738,0.116463124294444,"AKT1",1
"R-HSA-193692","R-HSA-193692","Regulated proteolysis of p75NTR","1/32","11/2914",0.114563371203117,0.197347177106738,0.116463124294444,"NFKB1",1
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","1/32","11/2914",0.114563371203117,0.197347177106738,0.116463124294444,"STAT3",1
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","1/32","11/2914",0.114563371203117,0.197347177106738,0.116463124294444,"EP300",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/32","11/2914",0.114563371203117,0.197347177106738,0.116463124294444,"TP53",1
"R-HSA-416572","R-HSA-416572","Sema4D induced cell migration and growth-cone collapse","1/32","11/2914",0.114563371203117,0.197347177106738,0.116463124294444,"ROCK2",1
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","1/32","11/2914",0.114563371203117,0.197347177106738,0.116463124294444,"TP53",1
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","1/32","11/2914",0.114563371203117,0.197347177106738,0.116463124294444,"TP53",1
"R-HSA-75035","R-HSA-75035","Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex","1/32","11/2914",0.114563371203117,0.197347177106738,0.116463124294444,"CDK1",1
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","1/32","11/2914",0.114563371203117,0.197347177106738,0.116463124294444,"ESR1",1
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","2/32","55/2914",0.121182002779903,0.202377914687347,0.119431980625367,"PPP2CA/PPP2R1B",2
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","2/32","55/2914",0.121182002779903,0.202377914687347,0.119431980625367,"MAPK1/PPP2CA",2
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","1/32","12/2914",0.124323609619066,0.202377914687347,0.119431980625367,"MAPK1",1
"R-HSA-111932","R-HSA-111932","CaMK IV-mediated phosphorylation of CREB","1/32","12/2914",0.124323609619066,0.202377914687347,0.119431980625367,"CREB1",1
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","1/32","12/2914",0.124323609619066,0.202377914687347,0.119431980625367,"CSNK2A1",1
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","1/32","12/2914",0.124323609619066,0.202377914687347,0.119431980625367,"MAPK1",1
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","1/32","12/2914",0.124323609619066,0.202377914687347,0.119431980625367,"YAP1",1
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","1/32","12/2914",0.124323609619066,0.202377914687347,0.119431980625367,"EP300",1
"R-HSA-3301854","R-HSA-3301854","Nuclear Pore Complex (NPC) Disassembly","1/32","12/2914",0.124323609619066,0.202377914687347,0.119431980625367,"CDK1",1
"R-HSA-381070","R-HSA-381070","IRE1alpha activates chaperones","1/32","12/2914",0.124323609619066,0.202377914687347,0.119431980625367,"GSK3A",1
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","1/32","12/2914",0.124323609619066,0.202377914687347,0.119431980625367,"CTNNB1",1
"R-HSA-389359","R-HSA-389359","CD28 dependent Vav1 pathway","1/32","12/2914",0.124323609619066,0.202377914687347,0.119431980625367,"PAK1",1
"R-HSA-399954","R-HSA-399954","Sema3A PAK dependent Axon repulsion","1/32","12/2914",0.124323609619066,0.202377914687347,0.119431980625367,"PAK1",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/32","12/2914",0.124323609619066,0.202377914687347,0.119431980625367,"CTNNB1",1
"R-HSA-442720","R-HSA-442720","CREB1 phosphorylation through the activation of Adenylate Cyclase","1/32","12/2914",0.124323609619066,0.202377914687347,0.119431980625367,"CREB1",1
"R-HSA-844456","R-HSA-844456","The NLRP3 inflammasome","1/32","12/2914",0.124323609619066,0.202377914687347,0.119431980625367,"NFKB1",1
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","1/32","12/2914",0.124323609619066,0.202377914687347,0.119431980625367,"CREB1",1
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","4/32","177/2914",0.125845578234453,0.204194599522354,0.120504085100563,"CDK1/MAPK1/PPP2CA/PPP2R1B",4
"R-HSA-111931","R-HSA-111931","PKA-mediated phosphorylation of CREB","1/32","13/2914",0.133979586356554,0.210599162304208,0.124283695238645,"CREB1",1
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","1/32","13/2914",0.133979586356554,0.210599162304208,0.124283695238645,"EP300",1
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","1/32","13/2914",0.133979586356554,0.210599162304208,0.124283695238645,"MAPK1",1
"R-HSA-193639","R-HSA-193639","p75NTR signals via NF-kB","1/32","13/2914",0.133979586356554,0.210599162304208,0.124283695238645,"NFKB1",1
"R-HSA-428540","R-HSA-428540","Activation of RAC1","1/32","13/2914",0.133979586356554,0.210599162304208,0.124283695238645,"PAK1",1
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","1/32","13/2914",0.133979586356554,0.210599162304208,0.124283695238645,"CTNNB1",1
"R-HSA-8876198","R-HSA-8876198","RAB GEFs exchange GTP for GDP on RABs","1/32","13/2914",0.133979586356554,0.210599162304208,0.124283695238645,"AKT1",1
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","1/32","13/2914",0.133979586356554,0.210599162304208,0.124283695238645,"EP300",1
"R-HSA-8964616","R-HSA-8964616","G beta:gamma signalling through CDC42","1/32","13/2914",0.133979586356554,0.210599162304208,0.124283695238645,"PAK1",1
"R-HSA-912446","R-HSA-912446","Meiotic recombination","1/32","13/2914",0.133979586356554,0.210599162304208,0.124283695238645,"BRCA1",1
"R-HSA-202403","R-HSA-202403","TCR signaling","2/32","59/2914",0.13596404568527,0.213052694640782,0.125731631032124,"PAK1/NFKB1",2
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","3/32","119/2914",0.140092172598601,0.217460201642399,0.128332691981075,"EP300/CSNK2A1/ARNT",3
"R-HSA-211859","R-HSA-211859","Biological oxidations","1/32","14/2914",0.143532379612876,0.217460201642399,0.128332691981075,"ARNT",1
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","1/32","14/2914",0.143532379612876,0.217460201642399,0.128332691981075,"CTNNB1",1
"R-HSA-445355","R-HSA-445355","Smooth Muscle Contraction","1/32","14/2914",0.143532379612876,0.217460201642399,0.128332691981075,"PAK1",1
"R-HSA-5684264","R-HSA-5684264","MAP3K8 (TPL2)-dependent MAPK1/3 activation","1/32","14/2914",0.143532379612876,0.217460201642399,0.128332691981075,"NFKB1",1
"R-HSA-5693554","R-HSA-5693554","Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)","1/32","14/2914",0.143532379612876,0.217460201642399,0.128332691981075,"BRCA1",1
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","1/32","14/2914",0.143532379612876,0.217460201642399,0.128332691981075,"STAT1",1
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","1/32","14/2914",0.143532379612876,0.217460201642399,0.128332691981075,"STAT3",1
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","1/32","14/2914",0.143532379612876,0.217460201642399,0.128332691981075,"EP300",1
"R-HSA-927802","R-HSA-927802","Nonsense-Mediated Decay (NMD)","1/32","14/2914",0.143532379612876,0.217460201642399,0.128332691981075,"PPP2CA",1
"R-HSA-975957","R-HSA-975957","Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)","1/32","14/2914",0.143532379612876,0.217460201642399,0.128332691981075,"PPP2CA",1
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","2/32","62/2914",0.147311016819331,0.222400224196785,0.131248013442489,"MAPK1/PAK1",2
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","8/32","486/2914",0.1509117698963,0.222400224196785,0.131248013442489,"AKT1/MAPK1/PPP2CA/ROCK2/RPS6KA3/CREB1/PAK1/PPP2R1B",8
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","2/32","63/2914",0.15113795194721,0.222400224196785,0.131248013442489,"SMAD3/SMAD2",2
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","1/32","15/2914",0.152983056803355,0.222400224196785,0.131248013442489,"AKT1",1
"R-HSA-2028269","R-HSA-2028269","Signaling by Hippo","1/32","15/2914",0.152983056803355,0.222400224196785,0.131248013442489,"YAP1",1
"R-HSA-400685","R-HSA-400685","Sema4D in semaphorin signaling","1/32","15/2914",0.152983056803355,0.222400224196785,0.131248013442489,"ROCK2",1
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","1/32","15/2914",0.152983056803355,0.222400224196785,0.131248013442489,"EP300",1
"R-HSA-5693537","R-HSA-5693537","Resolution of D-Loop Structures","1/32","15/2914",0.152983056803355,0.222400224196785,0.131248013442489,"BRCA1",1
"R-HSA-5693568","R-HSA-5693568","Resolution of D-loop Structures through Holliday Junction Intermediates","1/32","15/2914",0.152983056803355,0.222400224196785,0.131248013442489,"BRCA1",1
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","1/32","15/2914",0.152983056803355,0.222400224196785,0.131248013442489,"TP53",1
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","1/32","15/2914",0.152983056803355,0.222400224196785,0.131248013442489,"CDK1",1
"R-HSA-69541","R-HSA-69541","Stabilization of p53","1/32","15/2914",0.152983056803355,0.222400224196785,0.131248013442489,"TP53",1
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","1/32","15/2914",0.152983056803355,0.222400224196785,0.131248013442489,"CTNNB1",1
"R-HSA-9604323","R-HSA-9604323","Negative regulation of NOTCH4 signaling","1/32","15/2914",0.152983056803355,0.222400224196785,0.131248013442489,"AKT1",1
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","1/32","16/2914",0.162332674665477,0.229294880321159,0.135316848907747,"MAPK1",1
"R-HSA-1810476","R-HSA-1810476","RIP-mediated NFkB activation via ZBP1","1/32","16/2914",0.162332674665477,0.229294880321159,0.135316848907747,"NFKB1",1
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","1/32","16/2914",0.162332674665477,0.229294880321159,0.135316848907747,"TP53",1
"R-HSA-392451","R-HSA-392451","G beta:gamma signalling through PI3Kgamma","1/32","16/2914",0.162332674665477,0.229294880321159,0.135316848907747,"AKT1",1
"R-HSA-3928664","R-HSA-3928664","Ephrin signaling","1/32","16/2914",0.162332674665477,0.229294880321159,0.135316848907747,"PAK1",1
"R-HSA-5205647","R-HSA-5205647","Mitophagy","1/32","16/2914",0.162332674665477,0.229294880321159,0.135316848907747,"CSNK2A1",1
"R-HSA-5627123","R-HSA-5627123","RHO GTPases activate PAKs","1/32","16/2914",0.162332674665477,0.229294880321159,0.135316848907747,"PAK1",1
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","1/32","16/2914",0.162332674665477,0.229294880321159,0.135316848907747,"MAPK1",1
"R-HSA-622312","R-HSA-622312","Inflammasomes","1/32","16/2914",0.162332674665477,0.229294880321159,0.135316848907747,"NFKB1",1
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","1/32","16/2914",0.162332674665477,0.229294880321159,0.135316848907747,"EP300",1
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","2/32","66/2914",0.162740103925753,0.229294880321159,0.135316848907747,"EP300/NFKB1",2
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","2/32","68/2914",0.170567427464564,0.239652000040994,0.14142903423995,"ROCK2/PAK1",2
"R-HSA-174048","R-HSA-174048","APC/C:Cdc20 mediated degradation of Cyclin B","1/32","17/2914",0.171582279362062,0.239738573664215,0.141480125088016,"CDK1",1
"R-HSA-5250941","R-HSA-5250941","Negative epigenetic regulation of rRNA expression","1/32","17/2914",0.171582279362062,0.239738573664215,0.141480125088016,"SIRT1",1
"R-HSA-202433","R-HSA-202433","Generation of second messenger molecules","1/32","18/2914",0.180732906583469,0.251128872959902,0.148202034476703,"PAK1",1
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","1/32","18/2914",0.180732906583469,0.251128872959902,0.148202034476703,"BRCA1",1
"R-HSA-69242","R-HSA-69242","S Phase","2/32","71/2914",0.182430795595916,0.252789780123267,0.149182207794834,"AKT1/RB1",2
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","1/32","19/2914",0.189785581648845,0.258705006963059,0.152673039580585,"CDK1",1
"R-HSA-1606322","R-HSA-1606322","ZBP1(DAI) mediated induction of type I IFNs","1/32","19/2914",0.189785581648845,0.258705006963059,0.152673039580585,"NFKB1",1
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","1/32","19/2914",0.189785581648845,0.258705006963059,0.152673039580585,"EP300",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/32","19/2914",0.189785581648845,0.258705006963059,0.152673039580585,"CTNNB1",1
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","1/32","19/2914",0.189785581648845,0.258705006963059,0.152673039580585,"CSNK2A1",1
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","1/32","19/2914",0.189785581648845,0.258705006963059,0.152673039580585,"EP300",1
"R-HSA-5260271","R-HSA-5260271","Diseases of Immune System","1/32","20/2914",0.198741319606439,0.268728182156019,0.158588149770843,"NFKB1",1
"R-HSA-5602358","R-HSA-5602358","Diseases associated with the TLR signaling cascade","1/32","20/2914",0.198741319606439,0.268728182156019,0.158588149770843,"NFKB1",1
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","1/32","20/2914",0.198741319606439,0.268728182156019,0.158588149770843,"EP300",1
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","1/32","21/2914",0.207601125332975,0.277721718198102,0.163895625262875,"CTNNB1",1
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","1/32","21/2914",0.207601125332975,0.277721718198102,0.163895625262875,"AKT1",1
"R-HSA-3928663","R-HSA-3928663","EPHA-mediated growth cone collapse","1/32","21/2914",0.207601125332975,0.277721718198102,0.163895625262875,"ROCK2",1
"R-HSA-933542","R-HSA-933542","TRAF6 mediated NF-kB activation","1/32","21/2914",0.207601125332975,0.277721718198102,0.163895625262875,"NFKB1",1
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","4/32","217/2914",0.21172113842934,0.282482049416335,0.16670490307713,"MAPK1/PPP2CA/CREB1/PPP2R1B",4
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","1/32","22/2914",0.216365993632091,0.283416913533703,0.167256606919544,"STAT3",1
"R-HSA-1500620","R-HSA-1500620","Meiosis","1/32","22/2914",0.216365993632091,0.283416913533703,0.167256606919544,"BRCA1",1
"R-HSA-525793","R-HSA-525793","Myogenesis","1/32","22/2914",0.216365993632091,0.283416913533703,0.167256606919544,"CTNNB1",1
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","1/32","22/2914",0.216365993632091,0.283416913533703,0.167256606919544,"TP53",1
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","1/32","22/2914",0.216365993632091,0.283416913533703,0.167256606919544,"TP53",1
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","1/32","22/2914",0.216365993632091,0.283416913533703,0.167256606919544,"CREB1",1
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","1/32","22/2914",0.216365993632091,0.283416913533703,0.167256606919544,"EP300",1
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","2/32","81/2914",0.222789715157133,0.290986029290316,0.171723470251897,"BRCA1/TP53",2
"R-HSA-109582","R-HSA-109582","Hemostasis","5/32","298/2914",0.224045550301307,0.290986029290316,0.171723470251897,"AKT1/MAPK1/PPP2CA/TP53/PPP2R1B",5
"R-HSA-201451","R-HSA-201451","Signaling by BMP","1/32","23/2914",0.225036909331875,0.290986029290316,0.171723470251897,"SMAD1",1
"R-HSA-5685938","R-HSA-5685938","HDR through Single Strand Annealing (SSA)","1/32","23/2914",0.225036909331875,0.290986029290316,0.171723470251897,"BRCA1",1
"R-HSA-5693616","R-HSA-5693616","Presynaptic phase of homologous DNA pairing and strand exchange","1/32","23/2914",0.225036909331875,0.290986029290316,0.171723470251897,"BRCA1",1
"R-HSA-1169091","R-HSA-1169091","Activation of NF-kappaB in B cells","1/32","24/2914",0.23361484738147,0.29673805109313,0.175117987670321,"NFKB1",1
"R-HSA-1474165","R-HSA-1474165","Reproduction","1/32","24/2914",0.23361484738147,0.29673805109313,0.175117987670321,"BRCA1",1
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","1/32","24/2914",0.23361484738147,0.29673805109313,0.175117987670321,"PAK1",1
"R-HSA-5693579","R-HSA-5693579","Homologous DNA Pairing and Strand Exchange","1/32","24/2914",0.23361484738147,0.29673805109313,0.175117987670321,"BRCA1",1
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","1/32","24/2914",0.23361484738147,0.29673805109313,0.175117987670321,"TP53",1
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","1/32","24/2914",0.23361484738147,0.29673805109313,0.175117987670321,"AKT1",1
"R-HSA-912694","R-HSA-912694","Regulation of IFNA signaling","1/32","24/2914",0.23361484738147,0.29673805109313,0.175117987670321,"STAT1",1
"R-HSA-111933","R-HSA-111933","Calmodulin induced events","1/32","25/2914",0.242100772946797,0.302175406432354,0.178326806767655,"CREB1",1
"R-HSA-111997","R-HSA-111997","CaM pathway","1/32","25/2914",0.242100772946797,0.302175406432354,0.178326806767655,"CREB1",1
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","1/32","25/2914",0.242100772946797,0.302175406432354,0.178326806767655,"AKT1",1
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","1/32","25/2914",0.242100772946797,0.302175406432354,0.178326806767655,"MAPK1",1
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","1/32","25/2914",0.242100772946797,0.302175406432354,0.178326806767655,"MAPK1",1
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","1/32","25/2914",0.242100772946797,0.302175406432354,0.178326806767655,"AKT1",1
"R-HSA-9007101","R-HSA-9007101","Rab regulation of trafficking","1/32","25/2914",0.242100772946797,0.302175406432354,0.178326806767655,"AKT1",1
"R-HSA-73894","R-HSA-73894","DNA Repair","3/32","157/2914",0.246519433448598,0.306928898575853,0.181132048547432,"EP300/BRCA1/TP53",3
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","1/32","26/2914",0.250495641505365,0.310343122357632,0.183146930009108,"AKT1",1
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","1/32","26/2914",0.250495641505365,0.310343122357632,0.183146930009108,"CTNNB1",1
"R-HSA-165159","R-HSA-165159","mTOR signalling","1/32","27/2914",0.258800398940208,0.315197580307323,0.18601175608803,"AKT1",1
"R-HSA-174184","R-HSA-174184","Cdc20:Phospho-APC/C mediated degradation of Cyclin A","1/32","27/2914",0.258800398940208,0.315197580307323,0.18601175608803,"CDK1",1
"R-HSA-445989","R-HSA-445989","TAK1 activates NFkB by phosphorylation and activation of IKKs complex","1/32","27/2914",0.258800398940208,0.315197580307323,0.18601175608803,"NFKB1",1
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","1/32","27/2914",0.258800398940208,0.315197580307323,0.18601175608803,"EP300",1
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","1/32","27/2914",0.258800398940208,0.315197580307323,0.18601175608803,"EP300",1
"R-HSA-5693571","R-HSA-5693571","Nonhomologous End-Joining (NHEJ)","1/32","27/2914",0.258800398940208,0.315197580307323,0.18601175608803,"BRCA1",1
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","1/32","27/2914",0.258800398940208,0.315197580307323,0.18601175608803,"YAP1",1
"R-HSA-174178","R-HSA-174178","APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1","1/32","28/2914",0.267015981632938,0.321313489859732,0.189621019442177,"PLK1",1
"R-HSA-179419","R-HSA-179419","APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint","1/32","28/2914",0.267015981632938,0.321313489859732,0.189621019442177,"CDK1",1
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","1/32","28/2914",0.267015981632938,0.321313489859732,0.189621019442177,"ESR1",1
"R-HSA-6781823","R-HSA-6781823","Formation of TC-NER Pre-Incision Complex","1/32","28/2914",0.267015981632938,0.321313489859732,0.189621019442177,"EP300",1
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","1/32","28/2914",0.267015981632938,0.321313489859732,0.189621019442177,"EP300",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","3/32","165/2914",0.270628195883994,0.324883013197253,0.191727549903998,"MAPK1/RPS6KA3/CREB1",3
"R-HSA-176409","R-HSA-176409","APC/C:Cdc20 mediated degradation of mitotic proteins","1/32","29/2914",0.275143316555927,0.328734176312664,0.194000288207955,"CDK1",1
"R-HSA-381119","R-HSA-381119","Unfolded Protein Response (UPR)","1/32","29/2914",0.275143316555927,0.328734176312664,0.194000288207955,"GSK3A",1
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","1/32","30/2914",0.283183321363626,0.335946251523358,0.198256446436302,"CSNK2A1",1
"R-HSA-1489509","R-HSA-1489509","DAG and IP3 signaling","1/32","30/2914",0.283183321363626,0.335946251523358,0.198256446436302,"CREB1",1
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","1/32","30/2914",0.283183321363626,0.335946251523358,0.198256446436302,"TP53",1
"R-HSA-913531","R-HSA-913531","Interferon Signaling","2/32","97/2914",0.288649694375453,0.341141664101274,0.201322484621867,"EGR1/STAT1",2
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","3/32","171/2914",0.288919182717978,0.341141664101274,0.201322484621867,"MAPK1/PPP2CA/PPP2R1B",3
"R-HSA-196854","R-HSA-196854","Metabolism of vitamins and cofactors","1/32","31/2914",0.291136904483031,0.341356323904346,0.201449164677254,"AKT1",1
"R-HSA-3214841","R-HSA-3214841","PKMTs methylate histone lysines","1/32","31/2914",0.291136904483031,0.341356323904346,0.201449164677254,"NFKB1",1
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","1/32","31/2914",0.291136904483031,0.341356323904346,0.201449164677254,"AKT1",1
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","1/32","32/2914",0.299004965203303,0.348146984947364,0.205456628136772,"CREB1",1
"R-HSA-6782135","R-HSA-6782135","Dual incision in TC-NER","1/32","32/2914",0.299004965203303,0.348146984947364,0.205456628136772,"EP300",1
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","1/32","32/2914",0.299004965203303,0.348146984947364,0.205456628136772,"MAPK1",1
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","1/32","33/2914",0.306788393764543,0.353932481797167,0.208870900631581,"MAPK1",1
"R-HSA-5685942","R-HSA-5685942","HDR through Homologous Recombination (HRR)","1/32","33/2914",0.306788393764543,0.353932481797167,0.208870900631581,"BRCA1",1
"R-HSA-6782210","R-HSA-6782210","Gap-filling DNA repair synthesis and ligation in TC-NER","1/32","33/2914",0.306788393764543,0.353932481797167,0.208870900631581,"EP300",1
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","1/32","33/2914",0.306788393764543,0.353932481797167,0.208870900631581,"AKT1",1
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","1/32","34/2914",0.314488071445742,0.360335990745349,0.21264988885673,"STAT1",1
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","1/32","34/2914",0.314488071445742,0.360335990745349,0.21264988885673,"EP300",1
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","1/32","34/2914",0.314488071445742,0.360335990745349,0.21264988885673,"MAPK1",1
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","1/32","35/2914",0.3221048706519,0.366558257778068,0.21632191837065,"STAT1",1
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","1/32","35/2914",0.3221048706519,0.366558257778068,0.21632191837065,"PAK1",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/32","35/2914",0.3221048706519,0.366558257778068,0.21632191837065,"CTNNB1",1
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","1/32","37/2914",0.337093279406167,0.381126904223654,0.224919508195187,"EP300",1
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","2/32","109/2914",0.337937573128727,0.381126904223654,0.224919508195187,"EP300/NFKB1",2
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","2/32","109/2914",0.337937573128727,0.381126904223654,0.224919508195187,"EP300/NFKB1",2
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","2/32","109/2914",0.337937573128727,0.381126904223654,0.224919508195187,"AKT1/PPP2CA",2
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","3/32","188/2914",0.341272254340865,0.384026720209071,0.226630815316434,"MAPK1/PPP2CA/PPP2R1B",3
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","1/32","38/2914",0.34446659016703,0.385037099675592,0.227227084040006,"CREB1",1
"R-HSA-2871837","R-HSA-2871837","FCERI mediated NF-kB activation","1/32","38/2914",0.34446659016703,0.385037099675592,0.227227084040006,"NFKB1",1
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","1/32","38/2914",0.34446659016703,0.385037099675592,0.227227084040006,"BRCA1",1
"R-HSA-1168372","R-HSA-1168372","Downstream signaling events of B Cell Receptor (BCR)","1/32","39/2914",0.351760425046952,0.391450207519064,0.231011736989382,"NFKB1",1
"R-HSA-6781827","R-HSA-6781827","Transcription-Coupled Nucleotide Excision Repair (TC-NER)","1/32","39/2914",0.351760425046952,0.391450207519064,0.231011736989382,"EP300",1
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","1/32","40/2914",0.358975613359473,0.39771967735642,0.23471162292458,"EP300",1
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","1/32","40/2914",0.358975613359473,0.39771967735642,0.23471162292458,"CTNNB1",1
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","1/32","41/2914",0.366112976049973,0.404735883413486,0.238852190274361,"CREB1",1
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","1/32","42/2914",0.373173325777227,0.407171763266692,0.240289708572161,"CTNNB1",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/32","42/2914",0.373173325777227,0.407171763266692,0.240289708572161,"STAT3",1
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","1/32","42/2914",0.373173325777227,0.407171763266692,0.240289708572161,"MAPK1",1
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","1/32","42/2914",0.373173325777227,0.407171763266692,0.240289708572161,"MAPK1",1
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","1/32","42/2914",0.373173325777227,0.407171763266692,0.240289708572161,"MAPK1",1
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","1/32","42/2914",0.373173325777227,0.407171763266692,0.240289708572161,"MAPK1",1
"R-HSA-202424","R-HSA-202424","Downstream TCR signaling","1/32","43/2914",0.380157466994194,0.413894385060778,0.244257019121355,"NFKB1",1
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","1/32","44/2914",0.387066196028045,0.420506040177336,0.248158843423687,"AKT1",1
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","1/32","46/2914",0.400660562701056,0.43340271621211,0.255769731028178,"ESR1",1
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","1/32","46/2914",0.400660562701056,0.43340271621211,0.255769731028178,"MAPK1",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","2/32","125/2914",0.40217630732917,0.434108760915391,0.256186398614922,"MAPK1/NFKB1",2
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","1/32","47/2914",0.407347753075381,0.438749292927017,0.258924977724011,"STAT1",1
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","1/32","48/2914",0.413962636891771,0.44397272144256,0.262007549328873,"NFKB1",1
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","1/32","48/2914",0.413962636891771,0.44397272144256,0.262007549328873,"BRCA1",1
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","1/32","49/2914",0.420505971022777,0.450030858349908,0.265582718540701,"MAPK1",1
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","1/32","51/2914",0.433380979487812,0.457963514038592,0.270264122546579,"EP300",1
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","1/32","51/2914",0.433380979487812,0.457963514038592,0.270264122546579,"EP300",1
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","1/32","51/2914",0.433380979487812,0.457963514038592,0.270264122546579,"EP300",1
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","1/32","51/2914",0.433380979487812,0.457963514038592,0.270264122546579,"EP300",1
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","1/32","51/2914",0.433380979487812,0.457963514038592,0.270264122546579,"EP300",1
"R-HSA-8951664","R-HSA-8951664","Neddylation","1/32","51/2914",0.433380979487812,0.457963514038592,0.270264122546579,"FBXO22",1
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","1/32","52/2914",0.439714129559901,0.462711730478306,0.273066250904849,"MAPK1",1
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","1/32","52/2914",0.439714129559901,0.462711730478306,0.273066250904849,"MAPK1",1
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","1/32","53/2914",0.445978681570412,0.466376874906273,0.275229211517357,"CSNK2A1",1
"R-HSA-397014","R-HSA-397014","Muscle contraction","1/32","53/2914",0.445978681570412,0.466376874906273,0.275229211517357,"PAK1",1
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","1/32","53/2914",0.445978681570412,0.466376874906273,0.275229211517357,"NFKB1",1
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","1/32","55/2914",0.458304861347334,0.478272500534666,0.282249335881084,"EP300",1
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","1/32","57/2914",0.470365186190871,0.488829935235554,0.288479735767346,"CTNNB1",1
"R-HSA-9020702","R-HSA-9020702","Interleukin-1 signaling","1/32","57/2914",0.470365186190871,0.488829935235554,0.288479735767346,"NFKB1",1
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","1/32","59/2914",0.482165209043974,0.500060000307461,0.295107083994358,"BRCA1",1
"R-HSA-416482","R-HSA-416482","G alpha (12/13) signalling events","1/32","61/2914",0.49371037065256,0.509930834575437,0.300932291200739,"ROCK2",1
"R-HSA-9612973","R-HSA-9612973","Autophagy","1/32","61/2914",0.49371037065256,0.509930834575437,0.300932291200739,"CSNK2A1",1
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","1/32","62/2914",0.499389048584252,0.513686485558035,0.303148663654632,"STAT3",1
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","1/32","62/2914",0.499389048584252,0.513686485558035,0.303148663654632,"TP53",1
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","1/32","63/2914",0.505006001755817,0.517348307297711,0.305309663404739,"BRCA1",1
"R-HSA-983705","R-HSA-983705","Signaling by the B Cell Receptor (BCR)","1/32","63/2914",0.505006001755817,0.517348307297711,0.305309663404739,"NFKB1",1
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","2/32","153/2914",0.507431468430081,0.518776480935632,0.306152490580408,"AKT1/MAPK1",2
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","1/32","64/2914",0.510561879673676,0.519863614323601,0.306794055120342,"EP300",1
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","1/32","64/2914",0.510561879673676,0.519863614323601,0.306794055120342,"PAK1",1
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","1/32","72/2914",0.552885983405165,0.561821514450097,0.331555230877739,"ESR1",1
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","1/32","76/2914",0.572696135942508,0.579609972593725,0.342052971165492,"NFKB1",1
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","1/32","76/2914",0.572696135942508,0.579609972593725,0.342052971165492,"CTNNB1",1
"R-HSA-983168","R-HSA-983168","Antigen processing: Ubiquitination & Proteasome degradation","1/32","88/2914",0.627158168410039,0.633454937169176,0.373829218963498,"FBXO22",1
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","1/32","106/2914",0.69644973809672,0.702032501528357,0.414299812558327,"NFKB1",1
"R-HSA-983169","R-HSA-983169","Class I MHC mediated antigen processing & presentation","1/32","115/2914",0.726241556313686,0.730599005651568,0.431158145011494,"FBXO22",1
"R-HSA-5663205","R-HSA-5663205","Infectious disease","1/32","126/2914",0.758822133475971,0.761851363549728,0.449601516210156,"CTNNB1",1
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","1/32","144/2914",0.804198714414544,0.805800703885489,0.475537927164817,"AKT1",1
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","1/32","160/2914",0.83749990555869,0.83749990555869,0.494245000245999,"AKT1",1
